15-Bio ApS: Financial statements 2025
CVR: 39889277
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
15-Bio ApS (CVR 39889277) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -6,875 and a net result of DKK -6,875 compared with DKK -8,126 the year before. Equity in the 2025 report amounted to DKK 11,547. The solvency ratio was 25.7%.
- Gross Profit
- DKK -6,875
- Profit/Loss
- DKK -6,875
- Equity
- DKK 11,547
- Total Assets
- DKK 45,005
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -7 t. | -7 t. | 12 t. | 0 |
| 2024 | - | -8 t. | -8 t. | 18 t. | - |
| 2023 | - | -5 t. | -5 t. | 27 t. | - |
| 2022 | - | -5 t. | -4 t. | 32 t. | - |
| 2021 | - | -6 t. | -7 t. | 35 t. | - |
Official annual report
How creditworthy is 15-Bio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
15-Bio ApS has published its annual report for 2024. Gross profit came to DKK -8,126, and the net result was DKK -8,126.
About 15-Bio ApS
15-Bio ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Rasmus Jorgensen Holdings ApS and Rasmus Jorgensen IVS. The management consists of Rasmus Jørgensen. The company is owned by Rasmus Jørgensen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,875 and a net result of DKK -6,875 compared with DKK -8,126 the year before. Equity in the 2025 report amounted to DKK 11,547.